NVTA - Invitae Corporation
| Previous Close | 17.41 |
| Open | 17.41 |
| Bid | 17.69 x 1000 |
| Ask | 17.71 x 1100 |
| Day's Range | 17.06 - 17.76 |
| 52 Week Range | 9.04 - 28.75 |
| Volume | 1,173,007 |
| Avg. Volume | 2,240,412 |
| Market Cap | 1.605B |
| Beta (3Y Monthly) | 3.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.87 |
| Earnings Date | Feb 12, 2018 - Feb 16, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.46 |
- Benzinga
InVitae Shares Bounce Back Following Analyst Rebuttal To Short Seller Allegations
On Oct. 11, a short seller article published on Seeking Alpha accused InVitae of being the next Theranos. The short seller implied InVitae’s strong revenue growth may have been obtained via fraudulent measures and InVitae is burning through cash at an irresponsible level. On Oct. 13, Capital Markets Laboratories CEO Ophir Gottlieb published a rebuttal to the Seeking Alpha story.
- PR Newswire
Research presented by Invitae at the American Society of Human Genetics Meeting Pushes Science and Practice of Genetics Forward
-- Advances in classification, new approaches to genetics in cancer and implications of primary and secondary findings for clinical care among wide-ranging data presentations -- HOUSTON , Oct. 17, 2019 ...
- Simply Wall St.
Does Invitae Corporation's (NYSE:NVTA) CEO Pay Matter?
In 2017 Sean George was appointed CEO of Invitae Corporation (NYSE:NVTA). This report will, first, examine the CEO...
- Thomson Reuters StreetEvents
Edited Transcript of NVTA earnings conference call or presentation 6-Aug-19 8:30pm GMT
Q2 2019 Invitae Corp Earnings Call
- InvestorPlace
5 Top Stock Trades for Thursday: NVDA, MTCH, NVTA
After dropping notably in the morning, stocks reversed and closed higher on the day. It leaves investors wondering what's next for the market. In the meantime, here are a few top stock trades. Top Stock Trades for Tomorrow 1: NvidiaNvidia (NASDAQ:NVDA) stock held the $172.50 level for four consecutive sessions. It was an impressive couple of days as bulls refused to break. On Wednesday, shares caught a boost after Goldman Sachs analysts took their price target from $179 to $192. InvestorPlace - Stock Market News, Stock Advice & Trading TipsAs shares reclaim the 20-day moving average, traders are shifting their outlook higher in the short term. Look to see if the stock can get back to $185, recent resistance earlier this month. Above it puts the high at $188.40 on the table, which comes into play near the 61.8% retracement. On the downside, watch $172.50. Below could send shares to the 50-day and possibly the 200-day moving average. Top Stock Trades for Tomorrow 2: Match GroupMatch Group (NASDAQ:MTCH) took a hit on Wednesday, as cracks start to show up on the chart. For now, shares are holding onto the 61.8% retracement. Below it will put Wednesday's lows on the table. The $65 level has been decent support, while the 200-day moving average is near $64 and the 50% retracement is near $63. On a rebound, see if MTCH stock can get back to $80. Top Stock Trades for Tomorrow 3: InvitaeI love Invitae (NASDAQ:NVTA) for the long term, but it would be foolish to ignore the charts. Invitae is taking out this month's low and falling below the 200-day moving average.Should shares continue lower, look for the 50% retracement just below $19. If it fails as support, look for a potential test of the May lows, with support in the low-$17s. At that point though, bulls may as well just ask for a January gap-fill and test of the 38.2% near $16.50. On the upside, NVTA needs too reclaim the 200-day moving average, as well as the $22 level, which is acting as short-term resistance. Top Stock Trades for Tomorrow 4: CintasCintas (NASDAQ:CTAS) has seen a widening range (blue lines) since popping higher in July. On Wednesday, shares jumped on better-than-expected earnings results. Thanks to its rally, CTAS is reclaiming the 50-day moving average and is approaching resistance at $270. Over $270 puts the 52-week high of $270.36 on the table, as well as a possible run to $276, which is recent trend resistance. Top Stock Trades for Tomorrow 5: ServiceNowServiceNow (NASDAQ:NOW) has been frustrating investors lately, but pleasing traders as it bounces between $250 range support and $270 range resistance. The setup is simple: traders can go long near $250 support and sell near $270 resistance. If shares break down below support, see if the 200-day supports it, along with the 61.8% retracement near $243.75. Over $270 -- which is also roughly the 78.6% retracement -- and a move toward $290 may be under way. Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long NVTA and NVDA. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 High-Yield Dividend Stocks Set for Growth * 10 Wonderful Companies Whose Valuations Aren't Quite Fair * 5 Stocks to Buy That Could Double in 2020 The post 5 Top Stock Trades for Thursday: NVDA, MTCH, NVTA appeared first on InvestorPlace.
- Zacks
Invitae (NVTA) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Invitae (NVTA) closed at $21.68, marking a -1% move from the previous day.
- PR Newswire
Invitae Expands Detect Program to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients
SAN FRANCISCO, Sept. 9, 2019 /PRNewswire/ -- Invitae (NVTA), a leading medical genetics company, today announced the availability of Detect Hereditary Pancreatic Cancer, a testing program that offers no-charge genetic testing and counseling to patients with pancreatic cancer. Genetic testing is recommended by clinicians for all pancreatic cancer patients to guide treatment choices and evaluate eligibility for clinical trials.
- PR Newswire
Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes
SAN FRANCISCO, Sept. 6, 2019 /PRNewswire/ -- Invitae Corporation (NVTA) announced the pricing on September 5, 2019 of $300.0 million aggregate principal amount of 2.00% convertible senior notes due 2024 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The aggregate principal amount of the offering was increased from the previously announced offering size of $200.0 million. Invitae granted the initial purchasers of the notes a 13-day option to purchase up to an additional $50.0 million principal amount of notes on the same terms and conditions.
- PR Newswire
Invitae Announces Proposed Offering of $200 Million of Convertible Senior Notes
SAN FRANCISCO, Sept. 4, 2019 /PRNewswire/ -- Invitae Corporation (NVTA) today announced its intention to offer, subject to market conditions and other factors, $200.0 million aggregate principal amount of convertible senior notes due 2024 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). In connection with the offering, Invitae expects to grant the initial purchasers of the notes a 13-day option to purchase up to an additional $30.0 million principal amount of notes on the same terms and conditions. Invitae intends to use the net proceeds from the offering of the notes to repay, including a prepayment premium, the $75.0 million in aggregate principal amount of notes outstanding under its 2018 Note Purchase Agreement and for international expansion, infrastructure investment, working capital and other general corporate purposes.
- InvestorPlace
4 Top Stock Trades for Wednesday: TWTR, WMT, CLF, NVTA
Tuesday marked the first trading session of September, as well as the first session in the holiday-shortened week, with U.S. equity markets closed on Monday in observance of Labor Day. It wasn't an easy session for traders to get reacquainted with though. Let's look at a few top stock trades. Top Stock Trades for Tomorrow 1: TwitterTwitter (NYSE:TWTR) stock have been moving really well and even on Tuesday, the early price action looked promising. Shares were trying to breakout of an ascending triangle, a bullish setup where rising uptrend support continues to squeeze a stock against a static level of resistance.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks to Buy for September That resistance came into play around $43. The stock was swiftly rejected from this level while the broader market was under notable pressure.However, uptrend support (blue line) is still holding strong, while the 20-day moving average is just below current levels.If these marks give way, $40 is on the table. A move over $43 could still trigger a breakout, but TWTR needs to close over this level. Top Stock Trades for Tomorrow 2: WalmartWalmart (NYSE:WMT) stock also continues to trade relatively well so far this month. However, the stock continues to struggle with this $114 to $115 level.In the last two months, WMT has found itself in this area on three separate occasions. Each test of $115 comes following a higher low, as highlighted by the purple arrows on the chart above.If the overall market falls apart, it will be harder for WMT stock to breakout. However, shares are sitting right under the trigger spot. A close over $115 could cause an even larger move to the upside, with $120 on many traders' radar.On the downside, I would really like to see the 20-day and 50-day moving averages hold as support. Top Stock Trades for Tomorrow 3: Cleveland-CliffsCleveland Cliffs (NYSE:CLF) is getting hammered on the day, falling about 15% on Tuesday. It's more than just a tough day though, as CLF falls below its 200-week moving average.Should CLF reclaim this area and hold it by Friday's close, bulls can breathe a sigh of relief. However, a close below this mark puts the $6 mark on the table for the struggling stock.Shares were putting in a series of lower highs (blue line) above the $10 mark, and since breaking down over the past few months, CLF has lost almost 50% from its 2019 highs. Down seven weeks in a row has made this one a tough stock to own.Let's see if CLF gets down to $6 and how it responds if it does. From here, investors either need to see CLF reclaim the 200-week or test $6. We'll have a better idea on CLF after that. Top Stock Trades for Tomorrow 4: InvitaeA 2019 favorite of mine, Invitae (NASDAQ:NVTA) has not been trading all that well as of late. Shares gapped up in early August on drastically better-than-expected quarterly results.But as the stock market chopped back and forth, NVTA wasn't able to demonstrate any relative strength. Worse, since that post-earnings gap up shares of Invitae have been under pressure, as downtrend resistance squeezes it lower.With the 50-day moving average turning from support to resistance, NVTA has a true test potentially coming up: Will the $21 to $22 area support the stock? This level was support in March and April before giving way and acting as resistance in May and June. * 7 Best Tech Stocks to Buy Right Now At the end of June, NVTA reclaimed this level and it again served as support. Let's see if it does again. Below it and the 200-day moving average may be on the table.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long NVTA. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Best Tech Stocks to Buy Right Now * 10 Mid-Cap Stocks to Buy * 8 Precious Metals Stocks to Mine For The post 4 Top Stock Trades for Wednesday: TWTR, WMT, CLF, NVTA appeared first on InvestorPlace.
- GuruFocus.com
Invitae Corp (NVTA) COO E Lee Bendekgey Sold $537,792 of Shares
COO of Invitae Corp (30-Year Financial, Insider Trades) E Lee Bendekgey (insider trades) sold 21,265 shares of NVTA on 08/19/2019 at an average price of $25.29 a share. Continue reading...
- GlobeNewswire
Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients
SMA Identified program offers genetic testing for SMA at no charge to individuals in the U.S. CAMBRIDGE, Mass. and SAN FRANCISCO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Biogen Inc. (BIIB) and Invitae Corporation (NVTA) today announced that SMA STAT, a new, rapid-turnaround genetic test for spinal muscular atrophy (SMA), will be offered at no charge to individuals in the U.S. as part of the SMA Identified program. The SMA STAT test reduces the time needed for genetic testing to help confirm a definitive diagnosis of SMA from 21 to four days, enabling individuals and physicians to plan and begin treatment earlier for what is often a life-threatening disease.
- Schaeffer's Investment Research
Citron Favorite Flashes Buy Signal
A short squeeze could also power the shares higher
- Simply Wall St.
Are Insiders Selling Invitae Corporation (NYSE:NVTA) Stock?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
- ETF Trends
Disruptive Health Care ETF Is Good For Your Genes
Reported on by Bloomberg’s Scarlet Fu, take a look at the ARK Genomic Revolution ETF (ARKG) if you are looking for an ETF that goes after companies involved in the genomics industry. Functioning as an ...
- InvestorPlace
5 Top Stock Trades for Thursday: TLT, WW, CVS, NVTA, MU
When volatility picks up, the moves get wild on both ends of the spectrum. In pre-market trading, the markets were set for another nice open, but traders suddenly found U.S. indices down about 1.5% going into the open. By the afternoon, equities were green. Let's look at some top stock trades in that mix. Top Stock Trades for Tomorrow 1: BondsAs you can see in the image above, there has been a flight to U.S. bonds, thus jolting the iShares 20+ Treasury Bond ETF (NASDAQ:TLT) higher by almost 10% in just a few trading sessions. Heck, just look at the volume from the last few days. It's impressive, but looking exhausted.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 3 Steps Every Investor Should Take Before the Next Stock Market Crash Now look at the weekly chart below, looking at the last four years.Notice the orange line up at the top of the chart. This is the RSI, which measures the overbought and oversold condition of a particular security. The TLT has only been this overbought two other times in the past four years. Each other time it's led to a substantial correction.Talk to any semi-seasoned trader though and they'll be quick to point out that the RSI alone is not reason enough to take a trade. But when sentiment is at an extreme and shares begin to act irrational, a temporary high/low may not be far off.Notice how seemingly everyone's become a currency and yield-curve expert over the past week? That's not a coincidence. This week, TLT blew out of its channel, but looks like it could be topping.Look for a check-back down one of three areas: prior channel resistance near $137, the 10-week moving average now at $133 and climbing or range resistance at $133 (black line). Top Stock Trades for Tomorrow 2: MicronMicron (NASDAQ:MU) took a tumble on Wednesday but was at least able to rally off the lows. Between the 20-day and 50-day moving averages now, let's see what's next before jumping in on MU.A further correction could send shares to $39, where it has the 50-day and 200-day moving averages. It also found this level as support in July.On a rally, see if it can reclaim the 20-day moving average. More importantly though, see how it handles the $44 to $45 area, a major zone of resistance in 2019. Over it puts the July highs back on the table. Top Stock Trades for Tomorrow 3: Weight WatchersWeight Watchers (NASDAQ:WW) erupted on Wednesday, climbing some 40% after the company reported earnings. Sheesh!Anyway, longs need to be careful. As if buying a 40% move isn't dangerous enough, WW is running right into its 200-day moving average. It's also hitting short-term channel resistance, although it's possible it breaks out.Over the 200-day sets up a potential rally for more gains, though. If it does, look for a move up to the $34.30 to $35 area. Although not pictured on the daily chart above, that's where WW will run into the 50-week and 200-week moving averages.If the 200-day acts as resistance, see how $25 holds as support on a potential pullback. Top Stock Trades for Tomorrow 4: CVS HealthLike it or not, CVS Health (NYSE:CVS) continues to slowly but surely improve. The stock is erupting more than 7% on strong earnings. Should shares finish strong on the day, it will be a perfect red-to-green candidate.For swing traders and investors, the stock continues to buoy nicely along channel support, making a perfect test just yesterday. Now up over $57, I want to see CVS hold above this zone. However, below $56 and the 20-day moving average may put channel support back in play.Should shares continue higher, look for a test of $60. That's where CVS will find channel resistance and the 200-day moving average. Top Stock Trades for Tomorrow 5: InvitaeInvitae (NASDAQ:NVTA) reported a really great quarter and rose nearly 20% in after-hours and pre-market trading. Those gains did not translate to the regular session though. The stock was up more than 13% at one point, but those gains have been axed in half toward the close. * 10 Stocks to Buy on the Trade War Dip If NVTA can hold up over $25, I'd consider it a positive development. Over Wednesday's high could easily send it to $30 if the broader market is cooperating. Below the 20-day and uptrend support, and NVTA may be headed to the 50-day currently at $22.33.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long NVTA. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy on the Trade War Dip * The 5 Highest-Rated Dow Stocks Right Now * 4 Cybersecurity Stocks to Buy for Long-Term Gains The post 5 Top Stock Trades for Thursday: TLT, WW, CVS, NVTA, MU appeared first on InvestorPlace.
Motley FoolInvitae Corp (NVTA) Q2 2019 Earnings Call Transcript
NVTA earnings call for the period ending June 30, 2019.
- Zacks
Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates
Invitae (NVTA) delivered earnings and revenue surprises of -8.33% and 5.92%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
-- Increased quarterly revenue by 43% and volume by 52% year-over-year -- -- Announced appointment of Sean George as chairman of the Board of Directors, retirement of Randy Scott as executive chairman, ...
- Motley Fool
Here's Why Genetic Testing Stocks Rose as Much as 25.4% in July
It was a great month to be a genetic testing company.
- Zacks
Implied Volatility Surging for Invitae (NVTA) Stock Options
Investors need to pay close attention to Invitae (NVTA) stock based on the movements in the options market lately.
- TheStreet.com
Swinging for the Small-Cap Biotech Fences Requires Accepting Strikeouts
Striking out is painful, but is not as impactful as missing out on the next potential home run because you're still brooding about whiffing on your last investment.
